Literature DB >> 22893453

Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.

Toshinari Takamura1, Hirofumi Misu, Tsuguhito Ota, Shuichi Kaneko.   

Abstract

Obesity is less common in the Asian population, but Asian people may be susceptible to obesity-associated metabolic dysregulation. Accumulating evidence suggests that insulin resistance is closely associated with ectopic fat accumulation in the liver. Whether this correlation is due to a causal relationship between the conditions has long been the subject of debate. Insulin resistance and type 2 diabetes affects liver pathology, typically leading to nonalcoholic fatty liver disease (NAFLD) by dynamically altering the hepatic genes involved in glucose and lipid metabolism. Conversely, how overnutrition induces hepatic insulin resistance has been studied intensively, and has been shown to involve excessive energy flux into mitochondria, toxic lipids, reactive oxygen species, and hepatokines. In this review, we focus on NAFLD both as a consequence and as a cause of insulin resistance through lessons learned from the liver of patients with type 2 diabetes.

Entities:  

Mesh:

Year:  2012        PMID: 22893453     DOI: 10.1507/endocrj.ej12-0228

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  36 in total

1.  Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population.

Authors:  Yasushi Imamura; Hirofumi Uto; Yasunari Hiramine; Kaori Hosoyamada; Sho Ijuin; Shiro Yoshifuku; Hironori Miyahara; Shigeho Maenohara; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2013-10-31       Impact factor: 7.527

2.  Ghrelin: a new treatment for non-alcoholic fatty liver disease?

Authors:  Patric J D Delhanty; Aart J van der Lely
Journal:  Endocrine       Date:  2012-09-20       Impact factor: 3.633

Review 3.  A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance.

Authors:  Raffaella Crescenzo; Francesca Bianco; Arianna Mazzoli; Antonia Giacco; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2016-02       Impact factor: 5.614

4.  Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.

Authors:  Young Eun Chon; Kyu Sik Jung; Kwang Joon Kim; Dong Jin Joo; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2014-08-14       Impact factor: 3.199

Review 5.  Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.

Authors:  Kareem Hassan; Varun Bhalla; Mohammed Ezz El Regal; H Hesham A-Kader
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 6.  Pathogenesis of nonalcoholic steatohepatitis.

Authors:  Wensheng Liu; Robert D Baker; Tavleen Bhatia; Lixin Zhu; Susan S Baker
Journal:  Cell Mol Life Sci       Date:  2016-02-19       Impact factor: 9.261

7.  Protective effect of Pinus koraiensis needle water extract against oxidative stress in HepG2 cells and obese mice.

Authors:  Sae Bom Won; Ga-young Jung; Juhae Kim; Young Shin Chung; Eun Kyung Hong; Young Hye Kwon
Journal:  J Med Food       Date:  2013-07-03       Impact factor: 2.786

Review 8.  Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Shao-Ren Zhang; Xiao-Ming Fan
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

9.  Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease.

Authors:  Doaa El Amrousy; Heba El Ashry; Sara Maher; Salwa Ganna; Samir Hasan
Journal:  Eur J Pediatr       Date:  2021-01-21       Impact factor: 3.183

10.  Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway.

Authors:  Zhong Q Wang; Xian H Zhang; Yongmei Yu; Russell C Tipton; Ilya Raskin; David Ribnicky; William Johnson; William T Cefalu
Journal:  Metabolism       Date:  2013-05-21       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.